The Bio Supply Management Alliance (BSMA), advocate of innovation in the supply chain of the biopharma industry, will organize the inaugural conference for supply chain management professionals in the biopharma industry in collaboration with MassBio. Celebrating its 10th anniversary, “Driving Innovations in the Global Bio-Pharma Supply Chain” will be the theme of the one-day conference to be held in Boston on April 26, 2017 at the Marriott Boston Cambridge Hotel.
Eminent executives and academicians of the biopharma industry will address the subjects of:
- Clinical Supply Chain,
- Strategic Sourcing,
- Product Lifecycle Management,
- Data Analytics,
- Transportation Technologies and
- Cold Chain Management.
The town hall environment will bring together:
- drug manufacturers,
- distributors,
- suppliers,
- service providers,
- technology enablers,
- management consultants,
- research institutions and academia.
Executives of the drug manufacturing companies will receive complimentary registration for the conference, while other members of MassBio will receive a 20% discount for conference registration.
Devendra Mishra, Executive Director of BSMA, observed, “Our collaboration with MassBio will further the adoption of efficient supply chain management strategies by developing, advancing, and disseminating best practices, knowledge, and research among the members of the global organization advocating healthcare advancement. We will endeavor to create an unprecedented network of professionals across the vertical functions of companies to maximize patient care in terms of efficiency, safety and integrity while ensuring governmental regulatory compliance."
Sarah MacDonald, Executive Vice President of the Massachusetts Biotechnology Council, remarked, “We are thrilled to partner with BSMA to further the principles and practices of supply chain management in the biopharma organizations we represent globally. We know our members will benefit by this horizontal management view of the business, improving efficiency, quality and security by fostering collaboration from suppliers to manufacturers to patients.”
|